baber/WOPTO huggingface dataset:
Patent JP-3222593-B2 (JP)
IPC: B41J2/05
Filed: 1992-12-28
Granted: 2001-10-29
Abstract: A recording head comprises a liquid emission member having an orifice through which an ink is emitted, an electro-thermal converter element for generating a thermal energy which is utilized to emit the ink introduced into the liquid emission member, and a functional element disposed on a same substrate on which the electro-thermal converter element is disposed for driving and controlling the electro-thermal converter element. The functional element includes an NPN bipolar transistor for driving the electro-thermal converter element and a CMOS transistor composed of an NMOS transistor and a PMOS transisfor for controlling an operation of the bipolar transistor. The NMOS transistor being formed in a P well diffusion layer in an N<-> type epitaxial growth layer which is grown on a surface of a P type semiconductor substrate. The PMOS transistor being formed in an N well diffusion layer in the N<-> type epitaxial growth layer which is grown on the surface of the P type semiconductor substrate. <IMAGE>
Patent JP-3240515-B2 (JP)
IPC: B29C45/76
Filed: 1998-12-10
Granted: 2001-12-17
Abstract: A method and apparatus for controlling injection in an injection molding machine meters and controls injection shot. Injection shot is metered into a heating cylinder of the injection molding machine, and the injection shot is then injected into a mold by advancing an injection screw in an injection direction within the heating cylinder. The injection screw is then retracted within the heating cylinder. <IMAGE>
Patent JP-H082795-B2 (JP)
IPC: A61K38/13
Filed: 1991-11-27
Abstract: The invention relates to a pharmaceutical composition for oral administration containing cyclosporin A and/or cyclosporin G as active ingredient, which possess advantageous absorption characteristics, and to a process for preparing this composition. The composition according to the invention comprises 1 part by mass of one or more cyclosporin(s) dissolved in 4 to 50 parts by volume of propylene glycol, 0 to 25 parts by volume of ethanol and 0.0 to 5 parts by mass of a polyoxyethylene/polyoxypropylene block polymer in homogenized state. Based on examinations carried out at 100 DEG  C., the stability of solutions prepared according to the invention does not differ from that of the commercially available Sandimmun oral solution.
Patent JP-3172178-B2 (JP)
IPC: C07H21/04
Filed: 1991-11-08
Granted: 2001-06-04
Abstract: Oligonucleotides containing multiple free amino groups attached directly to the phosphorus atoms of the phosphodiester linkages having the structure shown below.   <IMAGE>   wherein D=a ribonucleoside or deoxyribonucleotide; p=a 5' to 3'-phosphodiester or phosphoramidate linkage; n=1 to 20; a=1 to 20; b=1 to 20; c=1=20; z=0 to 20; t=1 to 100; and wherein for each repeating unit, "a" represents the same number or a different number than that number represented by "a" in every other repeating unit; and for each repeating unit "b" represents the same number or a different number than represented by "b" in every other repeating unit. Multiple reporter molecules can be incorporated into the oligonucleotide via the free amino groups allowing for increased probe sensitivity.
Patent JP-3796532-B2 (JP)
IPC: B21D17/04
Filed: 1995-06-16
Granted: 2006-07-12
Abstract: PCT No. PCT/GB95/01415 Sec. 371 Date Dec. 17, 1996 Sec. 102(e) Date Dec. 17, 1996 PCT Filed Jun. 16, 1995 PCT Pub. No. WO95/35196 PCT Pub. Date Dec. 28, 1995An apparatus for forming grooves in the cylindrical surfaces of tubes or rods has a passage through the apparatus with a grooving roller mounted adjacent the passage. The roller has a helically extending ridge formed on its circumference, with the ridge extending into the passage and the roller being mounted for rotation about an axis inclined to the axis of the passage. The angle of inclination of the axis is such that the ridge, where it extends into the passage, runs at right angles to the axis of the passage. The roller is made to rotate about the tube or rod as the tube passes through the apparatus.
Patent JP-H0572801-B2 (JP)
Inventor: ANDORIE UORUFU
IPC: A43B13/14
Filed: 1988-03-17
Abstract: PCT No. PCT/DE88/00164 Sec. 371 Date Dec. 21, 1988 Sec. 102(e) Date Dec. 21, 1988 PCT Filed Mar. 17, 1988 PCT Pub. No. WO88/08263 PCT Pub. Date Nov. 3, 1988.A running shoe comprising a front sole of hard plastic material for mounting gripping elements, and a support member arranged behind the rearmost gripping elements, of elastically deformable material. In order to ensure that it is better possible to maintain a foot attitude required for optimum running efficiency, the support member is a wedge member which increases in thickness in a rearward direction and which comprises a relatively hard but elastically pressure-deformable material, wherein the underside thereof is disposed approximately in one plane with the front sole, and the wedge member extends at least with its portion associated with the outer edge of the sole, into the shank region of the sole.
Patent JP-H0764562-B2 (JP)
IPC: C08F4/634
Filed: 1986-05-16
Abstract: A process for removing one or more contaminants of the formula TiCl<sub>3</sub>OR, in which R is an alkyl or aryl group, from a liquid phase comrising TiCl<sub>4</sub>, characterized in that the contaminants are reacted with an organic acid halide R'-C" O Cl, in which R' is an aryl or alkyl group, to precipitate an addition complex of the formula nTiCl<sub>4</sub>.R'-C "O OR, in which n is a number of from 0.3 to 3.0, and the addition complex is separated from the liquid phase.
Patent JP-3992297-B2 (JP)
IPC: A61K31/59
Filed: 1998-06-24
Granted: 2007-10-17
Abstract: Provided are vitamin D3 derivatives expressed by the following general formula Ä1Ü <CHEM> Äwherein, R1 and R2 are each a hydrogen atom, a trialkylsilyl group, an acetyl group, a methoxymethyl group, or a tetrahydropyranyl group; R3 and R4 are each a hydrogen atom, a hydroxyl group, an acyloxy group, an alkyloxy group, an alkylthio group or an alkyl group which is optionally substituted; R5, R6, R7 and R8 are each a hydrogen atom, a hydroxyl group, an alkyl group or an acyloxy group; R9 is a hydrogen atom, a hydroxyl group, an alkyl group or an alkylthio group; R10 is a hydrogen atom, an alkyl group or an alkyloxy group; A and B are each a hydrogen atom, a hydroxyl group, or together express a single bond; X and Y express a carbonyl oxygen, or one of them is a hydrogen atom and the other is a hydroxyl group or an acyloxy group; n is an integer of 0 to 2; m is an integer of 0 to 2Ü, and a method for manufacturing the derivatives. The compounds can be sued as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis and dermatitis.
Patent JP-4358906-B2 (JP)
IPC: B01D17/038
Filed: 1995-07-28
Granted: 2009-11-04
Abstract: PCT No. PCT/AU95/00460 Sec. 371 Date Jan. 29, 1997 Sec. 102(e) Date Jan. 29, 1997 PCT Filed Jul. 28, 1995 PCT Pub. No. WO96/04058 PCT Pub. Date Feb. 15, 1996A separation apparatus, particularly for separating two fluids having different densities or specific gravities, is described. The apparatus is provided with a baffle arrangement (22) located within cylindrical housing (3) comprising a plurality of conical-shaped baffles having sloping wall surfaces (24). The conical baffles may be arranged in a nested or stacked relationship or may be connected together to form a continuous helix. A convection current is set up within the apparatus such that one part of the flow is through the baffles in the direction from the base of the conical baffles to the centrally located aperture and the other part of the flow is along the interior walls of the apparatus in a gap between the peripheral edge of the base of the conical baffles and the interior wall. The material to be separated is discharged from the apparatus through a high level outlet acting as an overflow weir.
Patent JP-2544839-B2 (JP)
IPC: F16L55/163
Filed: 1990-04-09
Granted: 1996-10-16
Abstract: A method of repairing a pipeline and apparatus for use in such a method is disclosed where a sheet like repair material is set in position within the pipeline with the use of a settable substance, the repair material being carried into the pipeline on a core member (4) the carries an inflatable member, the inflatable member (1) extending axially along the core member (4) and at least partially around the core member (4) to define an annular or part annular enclosed space (9,10) extending along the core member (4), means (8,11) being provided to inflate or deflate the inflatable member when in position in the pipeline, the inflatable member further having an outer flexible surface portion fixed only at one axial end to the core member, the inflatable member (1) acting when inflated to press the repair material against the pipeline wall to be repaired with the inflatable member (1) being thereafter deflated with the apparatus being withdrawn from the pipeline in a direction whereby the outer wall portion of the inflatable member (1) is progressively everted and peeled away from the repair material.
Patent JP-3256236-B2 (JP)
IPC: C12Q1/68
Filed: 1994-08-31
Granted: 2002-02-12
Abstract: Nucleosides and linked nucleosides functionalized to include alkylthiol chemical functionality at ribofuranosyl positions, nucleosidic base positions, or on internucleoside linkages. In certain embodiments, the compounds of the invention further include steroids, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins attached to the nucleosides through the alkylthio group.
Patent JP-3696617-B2 (JP)
IPC: C12N5/10
Filed: 1992-12-14
Granted: 2005-09-21
Abstract: Tissue plasminogen activator (t-PA) variants with substitution of leucine for phenylalanine, histidine for arginine, serine for isoleucine and threonine for lysine at amino acid positions (274, 275, 276 and 277) respectively, of wild-type human t-PA are prepared. DNA sequences can be prepared that encode such variants, as well as expression vectors incorporating the DNA sequences, and host cells transformed with the expression vectors. The variants exhibit improved fibrin-specificity and can be used in a pharmaceutical preparation to treat a vascular disease or condition or to prevent fibrin deposition or adhesion formation or reformation in mammals.
Patent JP-H0720933-B2 (JP)
IPC: A61P25/28
Filed: 1991-06-25
Abstract: Compounds of formula (I) wherein W is (a) or (b) and R<7>, R<8>, R<9>, R<10>, R<11>, R<6>, R<5> and R<1> are as described herein.
Patent JP-3430441-B2 (JP)
IPC: A61F13/15
Filed: 1993-11-11
Granted: 2003-07-28
Abstract: PCT No. PCT/SE93/00964 Sec. 371 Date Aug. 1, 1995 Sec. 102(e) Date Aug. 1, 1995 PCT Filed Nov. 11, 1993 PCT Pub. No. WO94/10952 PCT Pub. Date May 26, 1994An absorbent article, particularly a diaper, has a central absorbent unit (1) which is comprised of an elongated absorbent body (2) enclosed between a liquid-permeable inner casing sheet (3) which lies proximal to the wearer in use, and a liquid-impermeable, outer casing sheet (4) which lies distal from the wearer in use. The absorbent unit is provided along its longitudinal edges (9) with liquid-impermeable folds (6) which are upstanding from the inner casing sheet and which form side-leakage barriers. The article has a side-flap (18) on each side of the absorbent unit (1). The side-flaps (18), optionally with associated edge (21, 23), are produced in the form of rectangular strips (10) completely separated from the absorbent unit (1) and are thereafter jointed thereto. A longitudinally extending edge-part (13) of each strip (10) is suitably folded double and the backwardly fold part (19) is joined to the outer casing sheet (3a, 4b or 4) of the absorbent unit (1)along a curved fastening line (21). When the aper is to be used, the side-flaps (18) are pulled-out laterally, the length of this extension, and therewith the width of the resulting side-flaps (18), being dependent on the curved shape of the fastening line (21). It is therewith possible to produce a curved contour (16) of the diaper for conforming to the wearer's legs with side-flaps (18) which originally have straight edges (11) The material from which the side-flaps (18) are made can be chosen quite independently of the inner and the outer casing sheets (3, 4), so as to avoid irritation of the wearer's skin while still fitting closely to the wearer's legs.
Patent JP-4033489-B2 (JP)
IPC: A61P31/04
Filed: 1996-09-18
Granted: 2008-01-16
Abstract: A method for preparing multivalent proteosomeamphiphilic determinant vaccines suitable for parenteral or mucosal administration using diafiltration or ultrafiltration technology. The amphiplilic determinants include lipopolysaccharides from gram negative bacteria, e.g. S. flexneri, P. shigelloides and S. sonnei. Proteosomes are obtained from group B type 2b meningococci. The active proteosomeamphiphilic determinant complexes (noncovalently complexes) of the vaccine are formed using defiltration or ultrafiltration to remove the detergent. The use of diafiltration or ultrafiltration decreases processing time and the opportunity for contamination and further permits the use of ambient temperature and efficient scaleup. In addition, the process permits the reliable and continuous monitoring of the dialysate which enhances the efficiency of the entire process. The time of dialysis for production of a lot of vaccine is reduced from 710 days to less than 72 hours and usually less than 48 or 4 hours. The use of the process optimizes the presence of each antigenic component in the preparation of multivalent vaccines.
Patent JP-H0725789-B2 (JP)
IPC: A61K9/00
Filed: 1991-09-06
Abstract: The invention relates to the novel compound mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions containing said compound.
Patent JP-3110047-B2 (JP)
IPC: C09D5/08
Filed: 1995-10-17
Granted: 2000-11-20
Abstract: An electrodepositable composition is provided comprising: (A) a non-gelled cationic resin which is derived from a polyepoxide and which contains in the resin molecule cationic salt groups and active hydrogen groups selected from aliphatic hydroxyl and primary and secondary amino; and present as a separate component (B) a fully capped polyisocyanate curing agent containing substantially no free isocyanate groups, The electrodepositable composition contains from about 0.02 to 1.0 milliequivalents phenolic hydroxyl groups per gram of resin solids, and from about 0.1 to 2.0 milliequivalents beta-hydroxy ester groups per gram of resin solids. The composition provides excellent corrosion resistance when electrodeposited over steel substrates, and does not require lead in the formulation nor the use of a conventional chrome rinse for the steel substrate pretreatment before electrodeposition.
Patent JP-3862238-B2 (JP)
IPC: H04M3/42
Filed: 1995-02-15
Granted: 2006-12-27
Abstract: PCT No. PCT/FI95/00071 Sec. 371 Date Dec. 27, 1995 Sec. 102(e) Date Dec. 27, 1995 PCT Filed Feb. 15, 1995 PCT Pub. No. WO95/23475 PCT Pub. Date Aug. 31, 1995A method and telecommunication system for controlling a call in a telecommunication system, which comprises a telecommunication network and a first subscriber station and one or more other subscriber stations, in which method is maintained a call in which the subscriber stations participate. In the method of the invention, to remove the desired subscriber stations from the call, the first subscriber station instructs the telecommunication network to remove one or more other subscriber stations from the call, and the telecommunication network removes one or more other subscriber stations from the call without the call being interrupted. In particular, upon issuance of an addition message containing subscriber IDs, the system adds any identified subscriber not yet participating in the call and removes any identified subscriber already participating in the call.
Patent JP-3615759-B2 (JP)
IPC: A61Q17/04
Filed: 1994-03-16
Granted: 2005-02-02
Abstract: The present invention relates to emulsion compositions which are useful for imparting both an artificial tan to human skin and for providing protection to the skin from the harmful effects of UV radiation. These compositions have good stability at acidic pH values, are highly substantive to the skin, and provide a natural looking tan.
Patent JP-4270410-B2 (JP)
IPC: E05B27/00
Filed: 1997-12-08
Granted: 2009-06-03
Abstract: A locking device for a lock cylinder (12) has an electronically controlled inhibiting element (2), which in an inhibit position (xS) blocks movement of a rotor (1) relative to a stator (6) and frees the rotor (1) in a free position (xF). A drive (9) exerts a working force (FA) on the inhibiting element (2), by which inhibiting element (2) can be reversibly transferred from the inhibit position (xS) into the free position (xF) and vice versa. A guide (52-57) is connected to the drive (9) and, at least outside the free position (xF), clearly defines the position of the inhibiting element (2). A restoring device (3) exerts a restoring force (FR) directed away from the free position (xF) on the inhibiting element (2), when that element is between the free position (xF) and a rest position (xO). In the rest position (xO) and in positions between the rest position (xO) and the free position (xF), the inhibiting element inhibits movement of the rotor (1). The locking device is resistant to external, undesired vibration and/or shock effects or magnetic action.
Patent JP-4117902-B2 (JP)
IPC: F02C7/00
Filed: 1995-05-03
Granted: 2008-07-16
Abstract: Improved methods for managing a population of metal components subject to fatigue failure are provided. The residual compressive stress in the critical surfaces of such components, especially in areas of high stress concentration, are measured non-destructively using x-ray diffraction techniques. The measured residual compressive stress is used as a management criteria. A component having a residual compressive stress greater than a predetermined value can be returned to service. However, once the measured residual compressive stress of a component galls below the predetermined value, it can either be removed permanently from service, or it can be reworked to increase its residual compressive stress and then returned to service. Additionally, by measuring the residual compressive stress of an individual component, the remaining service life of that individual component can be estimated. These methods for management of populations of such metal components allow for increasing the service life of the components in a safe and effective manner.
Patent JP-3229334-B2 (JP)
IPC: B08B1/00
Filed: 1998-01-30
Granted: 2001-11-19
Abstract: A dust and fiber control device for paper making apparatus is described. The device includes a wall in conjunction with a feed spout for providing a water curtain. The water curtain serves to capture and remove air suspended dust and fiber particles from ambient air. The device is positioned transversely to the motion of a paper web underneath the web between a drying cylinder and a rewinder. The water curtain device is utilized in conjunction with air flow devices for assisting in controlling the collection of air suspended dust and fiber particles from the ambient air.
Patent JP-3410476-B2 (JP)
IPC: C07D303/48
Filed: 1998-04-17
Granted: 2003-05-26
Abstract: The invention relates an epoxysuccinamide derivative represented <CHEM> by a formula (I): wherein R<1> represents a hydrogen atom, an alkyl or aminoalkyl group, R<2> represents an aminoalkyl group which may be substituted, an aryl group which may be substituted, a heterocyclic group which may be substituted, an aralkyl group which may be substituted, or an alkyl group substituted by a heterocyclic ring which may be substituted, or R<1> and R<2> may form a nitrogen-containing heterocyclic ring, which may be substituted, together with the adjacent nitrogen atoms, and R<3> and R<4> are the same or different from each other and independently represent a hydrogen atom, or an alkyl or aralkyl group, or a salt thereof, a preparation process thereof, and a medicine comprising such a derivative or salt as an active ingredient. This compound has a specific inhibitory activity for cathepsin L and family enzymes thereof, and is useful as an agent for preventing and treating metabolic osteopathy such as osteoporosis and hypercalcemia.
Patent JP-4068160-B2 (JP)
IPC: H01L21/00
Filed: 1998-03-26
Granted: 2008-03-26
Abstract: An integrated intrabay buffer, delivery, and stocker system including a pair of shuttles, capable, by themselves, of transferring a pod in an X-Z plane between the interbay transport system, the I/O ports of various process tools and a plurality of storage shelves provided along the wall of the tool bay. Advantageously, the present invention integrates together the process tools within a tool bay by providing a single transport mechanism shared by each tool, and by providing a single, large storage and buffer area for pods that is shared by each tool. This increases reliability and flexibility, and simplifies the hardware and software control. Additionally, the storage shelves may be provided above some or all of the process tools within the tool bay. Such an arrangement offers a substantially greater number of spaces to store a pod as compared to conventional tool bays. Moreover, as the space above processing tools is currently unused, in part because a clear, unobstructed path above the I/O ports of the processing tools must be available in conventional systems, the increased storage capacity according to the present invention may be provided without increasing the footprint of conventional tool bays.
Patent JP-4212653-B2 (JP)
IPC: F16H1/46
Filed: 1998-05-09
Granted: 2009-01-21
Abstract: The planetary gear according to the invention comprises a sun gear (2) connected to a driven central shaft (20), a ring gear (12), a group of first stepped planetary gears (8, 10) and a group of second stepped planetary gears (4, 6). The large step wheels (4) of the second stepped planetary gears engage the sun gear (2), the small step wheels (6) of the second stepped planetary gears simultaneously engage a pair of adjoining large step wheels (8) of the first stepped planetary gears and all small step wheels (10) of the first stepped planetary gears engage the ring gear (12). The gear allows for high transmission ratios having a small size and low inertia moment and offers excellent properties in relation to efficiency and transmission reliability.
Patent ES-2212866-B2 (ES)
Title: Sistema de separacion fraccionada de la biomasa integral del cardo cynara carcunculus l.
Inventor: FERNANDEZ GONZALEZ JESUS
IPC: A01F29/00
Filed: 2001-05-04
Granted: 2005-07-01
Abstract: Sistema de separación fraccionada de la biomasa
integral del cardo  Cynara  cardunculus L.   
     La invención consiste en un sistema de separación
fraccionada de la biomasa  integral de un cultivo de cardo
( Cynara cardunculus L. ), cosechada seca de  forma integral
mediante empacadora. Está caracterizado por una actuación 
secuencial de  unidades elementales que desempacan la biomasa,
disgregan los  componentes de los  capítulos, separan las hojas de
los tallos, dilaceran y  desmedulan los tallos y ramas y separan en
fracciones diferentes los distintos  componentes. Este sistema evita
las pérdidas que se producen en algunas  fracciones cuando se
utiliza para esta finalidad la maquinaria agrícola  convencional de
recolección de cereales. Las diversas fracciones se pueden  utilizar
para la producción de energía, producción de aceite y como materias 
primas para la industria de la celulosa y fibras.